Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
NFL Players Almost 4 Times More Likely to Die From ALS
04/25/2022
Amyotrophic lateral sclerosis (ALS) incidence and mortality rates are nearly 4 times higher in National Football League (NFL) players compared with the US male population, according to a study published in JAMA Network Open.
Amyotrophic lateral sclerosis (ALS) incidence and mortality rates are nearly 4 times higher in National Football League (NFL) players compared with the US male population, according to a study published in JAMA Network Open.
Amyotrophic lateral sclerosis...
04/25/2022
Neurology
News
Testing Central Auditory Processing May Reveal Preclinical Alzheimer Disease
04/20/2022
Behavioral central auditory processing assessments differentiated between people with mild cognitive impairment and healthy, age-matched control subjects and may help identify older adults at risk of Alzheimer disease.
Behavioral central auditory processing assessments differentiated between people with mild cognitive impairment and healthy, age-matched control subjects and may help identify older adults at risk of Alzheimer disease.
Behavioral central auditory...
04/20/2022
Psych Congress Network
News
Game-Based, At-Home Motor Rehab Frees Therapist Time for Behavioral Intervention
04/20/2022
A flipped model of care for stroke rehab, in which therapist time is focused on behavioral intervention and motor practice is self-managed through video games, produced greater gains in quality of everyday arm use compared with traditional...
A flipped model of care for stroke rehab, in which therapist time is focused on behavioral intervention and motor practice is self-managed through video games, produced greater gains in quality of everyday arm use compared with traditional...
A flipped model of care for...
04/20/2022
Neurology

Advertisement

News
Dairy Products May Aggravate MS Symptoms in Patients With Casein Intolerance
04/13/2022
Study results show consuming cow’s milk may aggravate multiple sclerosis (MS) symptoms in a subset of patients with an intolerance to bovine casein.
Study results show consuming cow’s milk may aggravate multiple sclerosis (MS) symptoms in a subset of patients with an intolerance to bovine casein.
Study results show consuming...
04/13/2022
Neurology
News
Lemborexant Improves Sleep, Reduces Daytime Fatigue in Patients With Insomnia
04/11/2022
A dual orexin receptor antagonist, lemborexant, improves sleep onset and sleep maintenance in patients with insomnia and reduces daytime fatigue, according to a recent study.
A dual orexin receptor antagonist, lemborexant, improves sleep onset and sleep maintenance in patients with insomnia and reduces daytime fatigue, according to a recent study.
A dual orexin receptor...
04/11/2022
Psych Congress Network
News
Statin Use Associated With Lower Risk of Developing Parkinsonism in Older Adults
04/07/2022
Older adults taking statins had a 16% lower risk of developing parkinsonism compared with those not taking the drug, reports a new study published in Neurology.
Older adults taking statins had a 16% lower risk of developing parkinsonism compared with those not taking the drug, reports a new study published in Neurology.
Older adults taking statins had...
04/07/2022
Neurology

Advertisement

News
Almost a Third of Women With Endometriosis Experience Migraine, Study Finds
04/06/2022
Migraine is significantly more prevalent in women with endometriosis compared with women without the disorder, according to a study published in Frontiers in Endocrinology.
Migraine is significantly more prevalent in women with endometriosis compared with women without the disorder, according to a study published in Frontiers in Endocrinology.
Migraine is significantly more...
04/06/2022
Neurology
News
Dementia Cases Projected to Top 152 Million Globally by 2050, US Cases Could Double
04/06/2022
By 2050, the number of people with dementia is expected to increase from an estimated 57.4 worldwide in 2019 to 152.8 million, according to a study published in The Lancet Public Health.
By 2050, the number of people with dementia is expected to increase from an estimated 57.4 worldwide in 2019 to 152.8 million, according to a study published in The Lancet Public Health.
By 2050, the number of people...
04/06/2022
Neurology
News
Esketamine Shows Antidepressant Efficacy Regardless of Sleep Disturbance in Treatment-Resistant Depression
04/05/2022
Esketamine nasal spray initiated with an antidepressant outperformed placebo in easing TRD regardless of the presence of sleep disturbance and in improving sleep after 8 days of treatment.
Esketamine nasal spray initiated with an antidepressant outperformed placebo in easing TRD regardless of the presence of sleep disturbance and in improving sleep after 8 days of treatment.
Esketamine nasal spray initiated...
04/05/2022
Psych Congress Network

Advertisement

News
Mortality Risk Higher With ASD, ADHD
04/05/2022
ASD and ADHD are associated with a significantly increased risk of all-cause mortality, suggests a systematic review and meta-analysis published in JAMA Pediatrics.
ASD and ADHD are associated with a significantly increased risk of all-cause mortality, suggests a systematic review and meta-analysis published in JAMA Pediatrics.
ASD and ADHD are associated with...
04/05/2022
Psych Congress Network

Advertisement

Advertisement

News

Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology
Hands holding a head in profile with an illustrated heart over brain
News
Antiseizure Meds May Increase Cardiovascular Risk in Older Adults With Epilepsy
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy...
10/21/2024
Neurology
FDA approval stamp
News
FDA Approves Infusion Treatment for Advanced Parkinson Disease in Adults
10/18/2024
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa...
10/18/2024
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
News
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to...
10/15/2024
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use